Mettler-Toledo International, Inc. (NYSE:MTD) Shares Bought by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. boosted its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 10.3% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,793 shares of the medical instruments supplier's stock after buying an additional 355 shares during the quarter. Crossmark Global Holdings Inc.'s holdings in Mettler-Toledo International were worth $4,479,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in MTD. Alliancebernstein L.P. grew its position in shares of Mettler-Toledo International by 9.9% in the 4th quarter. Alliancebernstein L.P. now owns 583,181 shares of the medical instruments supplier's stock worth $713,627,000 after buying an additional 52,726 shares during the period. Geode Capital Management LLC lifted its stake in Mettler-Toledo International by 2.0% during the 4th quarter. Geode Capital Management LLC now owns 558,471 shares of the medical instruments supplier's stock valued at $682,340,000 after acquiring an additional 11,032 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in Mettler-Toledo International by 6.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 455,739 shares of the medical instruments supplier's stock valued at $557,680,000 after acquiring an additional 25,873 shares during the period. GAMMA Investing LLC lifted its stake in shares of Mettler-Toledo International by 131,246.3% in the 1st quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier's stock worth $456,018,000 after purchasing an additional 385,864 shares during the period. Finally, T. Rowe Price Investment Management Inc. lifted its stake in shares of Mettler-Toledo International by 36.1% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 363,107 shares of the medical instruments supplier's stock worth $444,327,000 after purchasing an additional 96,300 shares during the period. 95.07% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

MTD has been the subject of a number of research analyst reports. Barclays began coverage on shares of Mettler-Toledo International in a report on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price objective for the company. Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price target for the company in a research report on Monday, April 7th. Wells Fargo & Company raised their price target on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research report on Monday, May 5th. Bank of America lifted their target price on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research report on Thursday, June 26th. Finally, Wall Street Zen downgraded Mettler-Toledo International from a "buy" rating to a "hold" rating in a research report on Monday, May 5th. Seven equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $1,280.90.

Mettler-Toledo International Stock Performance

MTD traded down $12.63 on Friday, hitting $1,223.62. The company had a trading volume of 118,779 shares, compared to its average volume of 150,546. The stock has a fifty day moving average price of $1,165.26 and a 200-day moving average price of $1,195.64. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,546.93. The stock has a market capitalization of $25.43 billion, a price-to-earnings ratio of 30.51, a P/E/G ratio of 3.76 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The company had revenue of $883.74 million for the quarter, compared to analyst estimates of $876.61 million. During the same quarter in the previous year, the firm earned $8.89 earnings per share. The firm's quarterly revenue was down 4.6% compared to the same quarter last year. Analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of the firm's stock in a transaction on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the completion of the sale, the director directly owned 120 shares of the company's stock, valued at $139,191.60. This trade represents a 89.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.94% of the company's stock.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.